drugset / Trial / NCT01748253

ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT)

NCT01748253

Unknown 80 enrolled Acrobat Trial Group
RandomizedParallel-groupOpen-labelTreatment

Summary

Evaluation of 24-hour antihypertensive effect of long-acting ARB-CCB tablet administrated to hypertensive patients with atrial fibrillation, and comparison of 24-hour antihypertensive effect of long-acting ARB-CCB tablet between morning administration and bedtime administration.

Timeline

Start
2012-11
Primary completion
2013-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amlodipine Other / unclassified Oral
Comparator Telmisartan Other / unclassified Oral

Indications